Steminent Biotherapeutics Inc.
7729
Rank in Stocks
#11835
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Share Price
$6.51
Last synced: 2026-11-10
Market Cap
$525.11M
Change (1 day)
6.22%
Change (1 year)
410.55%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Steminent Biotherapeutics Inc. (7729)
Category
Healthcare
Operating Margin for Steminent Biotherapeutics Inc. (7729)
Operating Margin as of November 2026 TTM: 0.00%
According to Steminent Biotherapeutics Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Steminent Biotherapeutics Inc. from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | -13,970.14% | -9.53% |
| 2022 | -15,442.14% | 333.27% |
| 2021 | -3,564.12% | 4,170.96% |
| 2020 | -83.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Steminent Biotherapeutics Inc.'s operating margin
What was Steminent Biotherapeutics Inc.'s operating margin in 2025?
In 2025, Steminent Biotherapeutics Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Steminent Biotherapeutics Inc.'s operating margin changed since 2020?
From 2020 to 2025, Steminent Biotherapeutics Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2022 (-15,442.14%).
How does Steminent Biotherapeutics Inc.'s operating margin compare with similar companies?
Steminent Biotherapeutics Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.